doi: 10.3389/fphar.2020.00886 Received 18 December 2019 Accepted 29 May 2020 Published 16 June 2020 Volume 11 - 2020 Edited by Bjorn Johansson, Karolinska Institutet (KI), Sweden Reviewed by Chieh-Hsin Lin, Kaohsiung Chang Gung Memorial Hospital, Taiwan
The FDA states that when taking a drug for its approved use, you can be sure the agency has conducted a careful evaluation of its benefits and risks for that use, the decision to use the drug is supported by strong scientific data, and there is approved drug labeling for healthcare providers on how to use the drug safely and effectively for that use (FDA)
To view a copy of this license, visit About this article Cite this article Alsante, A.N., Thornton, D.C.O
Lancet 2021;398:143155
GLP-1 medications have demonstrated cardiovascular benefits in clinical trials, including reduced risk of major cardiovascular events